Ampio Pharmaceuticals, Inc.
AMPE
Revenue
469.21k
▲3.26k▲0.6990%
3 Months ChangeAssets
5.74M
▼-1.91M▼-24.98%
3 Months ChangeLiabilities
2.38M
▲105.00k▲4.62%
3 Months ChangeFree Cash Flow
-4.94M
▼-716.00k▼-16.93%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-03-25
Form 8-K
ID: 0001558370-24-003858
2024-02-28
Form 8-K
ID: 0001558370-24-001983
2024-02-15
Form 8-K
ID: 0001558370-24-001200
2024-01-25
Form 8-K
ID: 0001558370-24-000546
2024-01-11
Form 8-K
ID: 0001558370-24-000210
2023-11-14
Form 10-Q
ID: 0001558370-23-019022
2023-11-02
Form 8-K
ID: 0001558370-23-017334
2023-10-27
Form 8-K
ID: 0001558370-23-016937
2023-10-06
Form 8-K
ID: 0001558370-23-016278
2023-10-04
Form 8-K
ID: 0001558370-23-016236